Beranda › Obesitas › Minnesota
Uji klinis Obesitas di Minnesota
29 studi untuk Obesitas mencari peserta di lokasi di Minnesota.
Kota di Minnesota
Teks studi resmi (Bahasa Inggris)
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- International Diabetes Center, Minneapolis
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07533175A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- International Diabetes Center, Minneapolis
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07564414A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- University of Minnesota, Minneapolis
- Synexus Clinical Research US-MN, Richfield
Menerima pesertaFase 3
Usia 8 hingga 18 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07253285A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- Headlands Research - Twin Cities, Maplewood
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07823608A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- University of Minnesota Masonic Children's Hospital, Minneapolis
- Mayo Clinic - PIN, Rochester
- Children's Minnesota Pediatric Endocrinology Clinic & McNeeley Diabetes Center, Saint Paul
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06672549A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Headlands Research-Twin Cities, Maplewood
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07369011Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Fairview Health Services M Health Fairview St Johns Hospital, Maplewood
- Minneapolis Heart Institute Foundation, Minneapolis
Menerima pesertaFase 3
Usia 45 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07037433A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Mankato
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743450Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Mankato Clinic, Mankato
- Fairview Health Services M Health Fairview St Johns Hospital, Maplewood
- University of Minnesota, Minneapolis
Menerima pesertaFase 3
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07037459A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- International Diabetes Center At Park Nicollet, Minneapolis
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07351045First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671
- Research Site, Dilworth
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 25 hingga 75 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07815678Exercise Response in Humans With Obesity
- Mayo Clinic in Rochester, Rochester
Menerima pesertaStudi observasional
Usia 20 hingga 45 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT05857150A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Mankato
- ACCOMPLISH-2 Research Site, Minneapolis
Menerima pesertaFase 3Sukarelawan sehat diterima
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07654374tDCS With Cognitive Training to Reduce Impulsivity and Weight in Veterans With Obesity
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT05225233Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Children's Hospitals and Clinics of Minnesota, Minneapolis
Menerima pesertaFase 2
Usia 7 hingga 25 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05082519Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Mankato
- ACCOMPLISH-1 Research Site, Richfield
Menerima pesertaFase 3
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT07654361Upper Body Subcutaneous Exosome Release in Response to a Meal in Obesity
- Mayo Clinic in Rochester, Rochester
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT07031297Fibrosis Lessens After Metabolic Surgery
- Mayo Clinic, Rochester
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06374875A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity
- Clinical Research Institute of Minnesota, Minneapolis
Menerima pesertaFase 4
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT07728383Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
- Minneapolis VA Health Care System, Minneapolis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT06390345Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial
- Mayo Clinic, Rochester
Menerima peserta
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 11 Jun 2026 · NCT06770049Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation
- Mayo Clinic in Rochester, Rochester
Menerima pesertaFase awal 1Sukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT06416969Circadian Rhythms in Human Adipose
- Mayo Clinic, Rochester
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 14 Apr 2026 · NCT06891534Regional Lipolysis Insulin Regulation
- Mayo Clinic in Rochester, Rochester
Menerima pesertaFase awal 1Sukarelawan sehat diterima
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT06392854Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
- Mayo Clinic, Rochester
Menerima pesertaFase 4Menyebutkan pembayaran untuk peserta
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 11 Mar 2026 · NCT07213466Insulin Regulation of Lipolysis and Lipolysis Proteins
- Mayo Clinic in Rochester, Rochester
Menerima pesertaFase awal 1Sukarelawan sehat diterima
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 28 Jan 2026 · NCT03866408Project SHINE (Sleep Health INitiative for Equity): Culturally Informing a Sleep Extension Intervention for African American Adults
- University of Minnesota, Minneapolis
Menerima pesertaFase 1/2
Usia 21 hingga 75 · Semua jenis kelamin · Diperbarui 17 Des 2025 · NCT06226077Weight Loss Through Mayo Clinic Diet
- Mayo Clinic in Rochester, Rochester
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 7 Okt 2025 · NCT06862375Tirzepatide in PWS, HO and GNSO
- Children's Minnesota, Saint Paul
Menerima pesertaFase 4
Usia 18 hingga 26 · Semua jenis kelamin · Diperbarui 16 Sep 2025 · NCT06901245Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.